BlackRock Fund Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $7K | Buy |
10
+3
| +43% | +$2.1K | ﹤0.01% | 4016 |
|
|
2016
Q3 | $7K | Sell |
7
-85
| -92% | -$85K | ﹤0.01% | 4016 |
|
|
2016
Q2 | $71K | Sell |
92
-19
| -17% | -$14.7K | ﹤0.01% | 3748 |
|
|
2016
Q1 | $77K | Sell |
111
-9
| -8% | -$6.24K | ﹤0.01% | 3724 |
|
|
2015
Q4 | $117K | Buy |
120
+3
| +3% | +$2.93K | ﹤0.01% | 3700 |
|
|
2015
Q3 | $124K | Sell |
117
-3
| -3% | -$3.18K | ﹤0.01% | 3646 |
|
|
2015
Q2 | $247K | Buy |
120
+65
| +118% | +$134K | ﹤0.01% | 3444 |
|
|
2015
Q1 | $52K | Sell |
55
-3
| -5% | -$2.84K | ﹤0.01% | 3695 |
|
|
2014
Q4 | $60K | Buy |
58
+4
| +7% | +$4.14K | ﹤0.01% | 3662 |
|
|
2014
Q3 | $56K | Sell |
54
-4
| -7% | -$4.15K | ﹤0.01% | 3699 |
|
|
2014
Q2 | $113K | Sell |
58
-464
| -89% | -$904K | ﹤0.01% | 3603 |
|
|
2014
Q1 | $1.12M | Buy |
522
+15
| +3% | +$32.1K | ﹤0.01% | 3186 |
|
|
2013
Q4 | $1.17M | Sell |
507
-514
| -50% | -$1.19M | ﹤0.01% | 3184 |
|
|
2013
Q3 | $2.9M | Buy |
1,021
+137
| +15% | +$389K | ﹤0.01% | 3057 |
|
|
2013
Q2 | $8.17M | Buy |
+884
| New | +$8.17M | ﹤0.01% | 2379 |
|